Atlus doesn't want to rush into a Metaphor: ReFantazio sequel

, by Thibaut

Atlus doesn't want to rush into a Metaphor: ReFantazio sequel

Back when it released in October 2024, Metaphor: ReFantazio was a critical success. The latest RPG from the Persona devs was praised by critics and sold over two million copies worldwide.

In an interview with Game Informer, Katsura Hashino, the game's director, said that while a sequel may one day be released, he prefers not to rush into it for now.

"When we set out to create this game, we had the ambition to make it one of our franchises at Atlus, a real pillar...

That said, even though we've had some success, we don't want to rush into releasing a sequel. We really want to think it through and make sure that if we continue this series, we create something that builds on the values we've instilled in this game and lives up to the expectations of the fans."

Source: gameinformer.com

You probably also gonna like...

  • Metaphor: ReFantazio is coming to Switch 2 on November 12

    The excellent RPG from Atlus released in 2024 is getting another lease at life on the Switch 2 this year. We’re talking, of course, about Metaphor: ReFantazio. This version will be available on November 12, 2026, on Nintendo’s console.

  • Atlus is preparing a live stream for the first anniversary of Metaphor: ReFantazio

    Metaphor: ReFantazio was among the best games of 2024. This week, Atlus will pay tribute to its RPG with a special live stream. The broadcast will take place on October 10, 2025, starting at 5 p.m. (BST) on the Atlus West YouTube channel. The Japanese company promises "a special message" for…

  • Metaphor: ReFantazio has been named Game of the Year at the Japan Game Awards

    Just hours before the Tokyo Game Show opened, Japan honored the best games of the past year. The Japan Game Awards 2025 have announced their winners! Unsurprisingly, it was a game developed in Japan that won the top prize. Metaphor: ReFantazio took home the award for Best Game. Meanwhile, Clair Obscur:…